ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1366	National Cancer Institute	Html	en	Pruritus (PDQ®)–Health Professional Version	Expert-reviewed information summary about pruritus (itching of the skin) as a complication of cancer or its treatment. Approaches to the management and treatment of pruritus are discussed.	pruritus 0.960641 second-generation antihistamines 0.585479 skin type 0.575303 atopic dermatitis 0.673145 skin surface 0.599366 worst pruritus 0.717892 atopic dermatitis population 0.574946 severe non-dermatological pruritus 0.718081 skin lipids 0.573883 Acad Dermatol Venereol 0.589376 primary dermatitis 0.600506 significant skin breakdown 0.59383 blood flow 0.584198 allergic skin reactions 0.594569 patients 0.575543 Dermatol Venereol Leprol 0.585578 placebo-controlled study 0.5912 radiation therapy 0.686843 Int J Dermatol 0.586614 Pain Symptom Manage 0.63754 healthy skin 0.593613 dry skin 0.639653 neuropathic pruritus 0.745005 et al. 0.592668	skin cleansing 0.573636 treatment 0.596222 skin reactions 0.599238 Oncol Nurs Forum 0.699339 skin dermatitis 0.603221 Opioid-induced Pruritus 0.704011 skin 0.704869 uraemic pruritus 0.705232 PUBMED Abstract 0.858232 Altered skin integrity 0.588103 Skin care 0.624412 Acta Derm Venereol 0.596823 pruritus relief 0.700635 itch 0.57584 allergic contact dermatitis 0.578553 skin hydration 0.574125 Clin Exp Dermatol 0.593566 skin change 0.583853 aggravates dry skin 0.598514 chronic idiopathic urticaria 0.638535 cholestatic pruritus 0.69774 Dermatol Ther 0.606265 intractable pruritus 0.703673 chronic pruritus 0.736276	CLICK HERE
1494	National Cancer Institute	Html	en	Urethral Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of urethral cancer.	female urethral cancer 0.376591 major academic centers 0.28402 lymph node dissection 0.342065 urinary tract tumors 0.271423 annual incidence rates 0.28547 transitional cell carcinoma 0.949088 PDQ cancer information 0.378892 distal urethra 0.410475 commonly used tumor 0.321815 adjunctive radiation therapy 0.307204 cancer information summary 0.365437 definitive radiation 0.299917 2-cm tumor-free margin 0.279143 inguinal node dissection 0.345806 inguinal nodes 0.299311 anterior urethral carcinoma 0.459736 NCI PDQ cancer 0.276687 ipsilateral node dissection 0.459423 female urethra 0.380147 urethral catheter 0.320637 radiation therapy 0.634648 urethral cancer 0.577855 patient selection 0.261945 tumor margins 0.303956 single-center case series 0.440822	transitional cell mucosa 0.339607 ipsilateral palpable adenopathy 0.268507 urethral neoplasms 0.326534 2-cm margin proximal 0.288589 anterior vaginal wall 0.284136 node dissection 0.66141 anterior urethral cancers 0.391992 prostatic urethra 0.421315 proximal urethral cancers 0.428057 Intensity-modulated radiation therapy 0.317055 large tumors 0.285311 poor tumor control 0.307048 low-dose-rate iridium-192 sources 0.265079 frozen section confirmation 0.398049 End Results database 0.287533 inguinal adenopathy 0.28947 urethral cancers 0.578678 optimal surgical margin 0.277613 tumor 0.331558 stratified squamous epithelium 0.325971 pendulous urethra 0.304701 numerous periurethral glands 0.276798 inferior pubic rami 0.262509 low level 0.288208	CLICK HERE
1628	National Cancer Institute	Html	en	Urethral Cancer Treatment (PDQ®)–Patient Version	Urethral cancer occurs in men and women and can spread quickly to lymph nodes near the urethra. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for urethral cancer.	cancer treatment 0.362333 entire urethra 0.306444 lymph node dissection 0.557244 tissue 0.317299 body 0.398643 PDQ cancer information 0.410389 clinical trial search 0.378188 white blood cells 0.310278 bladder cancer 0.308764 clinical trials 0.773033 nearby lymph nodes 0.630197 cancer information summary 0.370147 clinical trial 0.499273 breast cancer prevention 0.294123 prostate gland 0.293841 patients 0.324988 invasive bladder cancer 0.301679 treatment clinical trial 0.300741 NCI PDQ cancer 0.319347 radiation therapy 0.651339 Urethral Cancer Treatment 0.356944 Treatment Editorial Board 0.30592 urethral cancer 0.837946 recurrent urethral cancer 0.334114	General information 0.298754 treatment 0.543719 new cancer treatments 0.306575 NCI-supported cancer 0.322826 cancer cells 0.450964 proximal urethral cancer 0.41852 urethral cancer spreads 0.344537 Cancer Information Service 0.306473 laser surgery 0.302658 patient 0.295185 treatment clinical trials 0.339398 anterior exenteration 0.294741 National Cancer Institute 0.373731 transurethral resection 0.314195 new treatment 0.34401 distal urethral cancer 0.388721 external radiation therapy 0.308401 cancer research process 0.298298 cancer clinical trials 0.402611 cancer information summaries 0.303961 comprehensive cancer information 0.304414 internal radiation therapy 0.302856 cancer 0.977674 standard treatment 0.307427	CLICK HERE
1637	National Cancer Institute	Html	en	Coenzyme Q10 (PDQ®)–Patient Version	Coenzyme Q10 is naturally made by the body and can be taken as a pill or injection. Studies have shown it to help protect the heart from damaging side effects of doxorubicin and to stimulate the immune system in cancer patients. Read about the results of clinical trials in cancer patients using coenzyme Q10 in this expert-reviewed summary.	cancer treatment 0.549646 body 0.488461 PDQ cancer information 0.604928 Cancer Complementary 0.504149 clinical trials 0.78289 CoQ10 supplements 0.61864 health care providers 0.511973 mg CoQ10 0.629362 cancer information summary 0.559761 alternative cancer therapies 0.503732 clinical trial 0.520374 CAM cancer research 0.490752 free radicals 0.529211 therapies 0.527068 conventional cancer therapies 0.505246 breast cancer patients 0.577878 patients 0.653188 cancer patients 0.613167 adjuvant therapy 0.48477 CoQ10 therapy 0.668716 NCI PDQ cancer 0.520611 cancer information database 0.499763 CoQ10 analogs 0.637275 Therapies Editorial Board 0.506627	cancer information 0.615008 treatment 0.639358 cancer prevention 0.483763 Complementary Therapies Editorial 0.521183 CoQ10 0.914047 Drug Administration 0.508672 Cancer Information Specialist 0.495609 cancer cells 0.510132 Cancer Information Service 0.558797 treatment clinical trials 0.486207 National Cancer Institute 0.655789 studies 0.570221 alternative medicine 0.536733 health care 0.547179 scientific journals 0.497807 Federal Trade Commission 0.485869 new treatment 0.531574 Cancer Care page 0.483491 breast cancer 0.62622 animal studies 0.506664 cancer clinical trials 0.505899 alternative therapies 0.521758 cancer information summaries 0.500194 cancer 0.924813	CLICK HERE
1674	National Cancer Institute	Html	en	Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood Langerhans Cell Histiocytosis.	Recurrent LCH 0.49021 cancer treatment 0.458844 childhood LCH lesions 0.545029 body 0.479436 high-risk multisystem LCH 0.563365 PDQ cancer information 0.430462 clinical trial search 0.417075 steroid therapy 0.417152 LCH lesions 0.646087 refractory childhood LCH 0.507141 Refractory LCH 0.491285 clinical trials 0.840496 LCH cells 0.723911 skin-only LCH 0.533026 cancer information summary 0.406099 clinical trial 0.546139 Langerhans cell histiocytosis 0.451003 patients 0.432765 LCH 0.976752 diagnose LCH 0.533565 lymph nodes 0.422079 treatment 0.665224 Progressive LCH 0.491974 BRAF gene 0.403636 LCH multisystem disease 0.521252	recurrent childhood LCH 0.508123 cancer cells 0.427036 pituitary gland 0.410888 childhood lch 0.600077 Adult LCH sections 0.511455 multisystem lch 0.599051 LCH trials 0.499932 LCH treatment 0.529717 treatment clinical trials 0.417639 National Cancer Institute 0.432317 effects cancer treatment 0.398781 small LCH lesions 0.540477 new treatment 0.409482 LCH bone lesions 0.547532 Adult LCH 0.522754 body systems 0.391142 LCH CNS 0.492291 bone marrow 0.4649 cancer clinical trials 0.44841 single-system lch 0.515862 progressive childhood LCH 0.507794 childhood LCH skin 0.522098 cancer 0.650545 information 0.432489	CLICK HERE
2027	National Cancer Institute	Html	es	Prevención del cáncer colorrectal (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a prevenir esta enfermedad.	Problemas renales 0.523957 siguientes factores 0.953317 voluntarios sanos 0.523051 Physician Data Query 0.604817 siguientes afecciones 0.551171 Estados Unidos 0.609005 posibles daños 0.574254 cuerpo).ampliar anatomía 0.537676 suficiente ejercicio 0.534096 prevención revisa 0.526315	menor riesgo 0.62051 PDQ Prevención 0.545917 Antecedentes familiares 0.532247 National Cancer Institute 0.526671 tumores benignos 0.586261 siguientes riesgos 0.524072 siguientes sumarios 0.58101 alto contenido 0.561192 Instituto Nacional 0.54913	CLICK HERE
3515	National Cancer Institute	Html	en	Types of Clinical Trials	Information about the several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials. Each type of trial is designed to answer different research questions.	agent studies 0.634708 large number 0.487416 treatment studies 0.534627 unnecessary follow-up tests 0.564207 standard treatments 0.500667 palliative care trials 0.620026 nutrition problems 0.486132 approach prevent cancer 0.592087 specific changes 0.499234 researchers 0.486118 cancer patients 0.507417 treatment trials 0.63562 Cancer prevention trials 0.614093 healthy people 0.501177 cancer screening trials 0.613302 chemoprevention studies 0.50869 health problems 0.485883 high risk 0.560244 radiation therapy 0.500589 new ways 0.649746 safe dose 0.499447 life 0.456389 answers questions 0.498733 action studies 0.564584 dietary supplements 0.491505	studies 0.663766 newer treatment trials 0.614927 certain medicines 0.490022 different research questions 0.599262 new treatment 0.895243 sleep disorders 0.486249 disease 0.456977 effective screening test 0.579302 certain type 0.487292 support groups 0.492526 people 0.64215 better quality 0.492262 genetic changes 0.499368 new treatment help 0.724782 tumors 0.439813 cancer clinical trials 0.74573 new places 0.514069 trials 0.781895 treatment help people 0.60481 cancer risk 0.517947 cancer 0.948957 prevention trials 0.744319 new cancer 0.533494 test new treatments 0.617153	CLICK HERE
3650	National Cancer Institute	Html	en	CRISPR: Genome Editing Comes of Age	A research article about a technique for gene editing known as CRISPR-Cas9. The technique has made it much easier and faster for cancer researchers to study mutations and test new therapeutic targets.	next-generation DNA sequencing 0.3795 new targets 0.314335 activator-like effector nucleases 0.397418 potentially druggable genes 0.453893 future combination therapy 0.360962 cancer therapy 0.352224 unique gene 0.31507 cancer growth 0.426678 abnormal regulatory networks 0.387625 cancer cell line 0.572636 short palindromic repeats 0.389333 genome editing 0.387426 new therapeutic targets 0.398394 genes 0.545435 cell division 0.314215 Cancer phenotypes 0.335586 human cell 0.318044 target genes 0.365123 lymphoma cells 0.394771 cancer drug targets 0.463263 drug resistant tumors 0.385077 David Baltimore 0.313639 Ji Luo 0.374003 drug resistance 0.449373	DNA sequencing 0.398873 potential combination therapies 0.357658 possible therapeutic approaches 0.357025 gene targets 0.319574 gene expression—it 0.322364 drug resistance question 0.384228 CRISPR libraries 0.319128 cancer cells 0.810099 cancer cell lines 0.446525 Dr. Luo 0.937997 Dr. Staudt 0.543567 CRISPR method 0.325677 CRISPR technology 0.334008 Hannover Medical School 0.387381 Cancer Research 0.352397 normal cells 0.431696 cancer researchers 0.367853 CRISPR 0.510355 cell death 0.314175 transformative technology 0.318261 technology 0.365907 Cancer Genome Atlas 0.450206 gene editing 0.330972 genetic changes 0.316809	CLICK HERE
4383	National Cancer Institute	Html	en	Anyone Can Get Skin Cancer	No matter if your skin is light, dark, or somewhere in between, everyone is at risk for skin cancer. Learn what skin cancer looks like, how to find it early, and how to lower the chance of skin cancer.	skin cancer 0.964567 UV rays 0.456636 dark band 0.53853 new mole 0.452556 dark patch 0.449539 body 0.421991 waxy bump 0.459872 Wear sunglasses 0.448376 ) bump. 0.459875 talk 0.420942 common sign 0.451092 skin light 0.47582 different types 0.451536 jagged scar 0.458002 exposure 0.417645 medical conditions 0.448166 sore 0.426359 UVB rays 0.455332 broad spectrum 0.449203 women 0.411421 UVA 0.425118 sunscreen 0.411184 high level 0.447722 dark skin 0.502452 changes 0.445228	skin conditions 0.464403 cancer cells 0.45646 cell skin cancer 0.522134 firm red lump 0.495754 sun 0.50802 skin tone 0.480812 eyes 0.41674 old growth 0.501248 different color 0.450303 men 0.411424 certain medicines 0.448412 advanced skin cancers 0.508812 younger children 0.460432 change 0.452939 long sleeves 0.44884 No. 0.411646 skin ulcers 0.466159 people 0.446457 doctor 0.48532 sunlight 0.422273 cause damage 0.452334 new growth 0.497988 risk 0.471314 low level 0.448421	CLICK HERE
15481	National Cancer Institute	Html	en	Non-NIH Funded Investigators Submitting Data	null	large storage amounts 0.821627 Institutional Certification 0.889959 documents 0.389667 hughessk@mail.nih.gov. 0.612992 additional information/clarification 0.581935 Institutional Certification forms 0.830868 accession number 0.58702 scientific community 0.570468 Non-NIH funded investigators 0.91136 completeness 0.389773 DSPs 0.387872 data submission process 0.811324 GPA analyst registers 0.892324 expectations 0.444558 genomic data 0.66091 value 0.344731	DCB 0.394534 data submission formats 0.897528 NCI subcommittee 0.653863 dbGaP submission 0.557126 Basic Study Information 0.821294 Shannon Hughes 0.637978 steps 0.351008 Studies 0.345806 extramural GPAs 0.729046 GDC staff 0.659949 storage fee 0.567724 plans 0.351639 data submission 0.961251 GPA analyst 0.950832 consideration 0.365649 Jennifer Strasburger 0.670922	CLICK HERE